Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Novocure Ltd (NVCR)

NASDAQ NMS - GLOBAL MARKET · Medical Devices

$16.31-0.72 (-4.23%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.90B
P/E (TTM)
EPS
Div Yield
52W Range
Beta

Company overview

No company overview is available for Novocure Ltd yet.

Peers in Medical Devices

All in industry →

Recent press releases

April 2026

3 months agoDEF 14AHealthcare

NovoCure seeks shareholder vote on 9 million shares for incentives

NVCRNovoCure Ltd

# 📰 What This Document Is This document is a Definitive Proxy Statement (DEF 14A). Think of it as a comprehensive instruction manual for the upcoming Annual General Meeting of Shareholders. This statement is required by the SEC and provides shareholders with all the necessary information needed to

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

Novocure Ltd has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
5,069,895 sh+453.4%
1,223,755 sh+1093.2%
8,530,665 sh-11.6%
900,496 sh+672.3%
646,666 sh-51.6%
1,019,969 sh+129.3%

People at Novocure Ltd

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$155.0M
NI -$34.3M
06/25
$151.0M
NI -$40.1M
09/25
$167.2M
NI -$37.3M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.33
Prior: $-0.36
Revenue sparkline